Array-based comparative genomic hybridization analysis reveals recurrent chromosomal alterations and prognostic parameters in primary cutaneous large B-cell lymphoma

Journal of Clinical Oncology

Volumn 24, Issue 2, 2006, Pages 296-305

  Dijkman, Remco ^a   Tensen, Cornelis P ^a   Jordanova, Ekaterina S ^a   Knijnenburg, Jeroen ^a   Hoefnagel, Juliette J ^a   Mulder, Aat A ^a   Rosenberg, Carla ^a   Raap, Anton K ^a   Willemze, Rein ^a   Szuhai, Kdroly ^a   Vermeer, Maarten H ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN DEPENDENT KINASE INHIBITOR 2B; CYCLOPHOSPHAMIDE; DOXORUBICIN; PEPTIDES AND PROTEINS; PREDNISONE; PROTEIN BCL 2; UNCLASSIFIED DRUG; VINCRISTINE SULFATE;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CHROMOSOME 14Q; CHROMOSOME 18Q; CHROMOSOME 2P; CHROMOSOME 9P; CHROMOSOME DELETION; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROGNOSIS; CHROMOSOME ABERRATION; DNA METHYLATION; DNA MICROARRAY; GENE AMPLIFICATION; GENETICS; HISTIOCYTIC LYMPHOMA; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION; PROMOTER REGION; SKIN TUMOR; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; CYCLIN-DEPENDENT KINASE INHIBITOR P15; DNA METHYLATION; FEMALE; GENE AMPLIFICATION; GENES, P16; HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL; MALE; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; PROMOTER REGIONS (GENETICS); SKIN NEOPLASMS;

EID: 33644828132     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.02.0842     Document Type: Article

References (45)

1. Willemze R, Jaffe ES, Burg G, et al: WHO-EORTC classification for cutaneous lymphomas. Blood 105:3768-3785, 2005
2. Berti E, Alessi E, Caputo R, et al: Reticulohistiocytoma of the dorsum. J Am Acad Dermatol 19:259-272, 1988
3. Grange F, Bekkenk MW, Wechsler J, et al: Prognostic factors in primary cutaneous large B-cell lymphomas: A European multicenter study. J Clin Oncol 19:3602-3610, 2001
4. Santucci M, Pimpinelli N, Arganini L: Primary cutaneous B-cell lymphoma: A unique type of low-grade lymphoma - Clinicopathologic and immunologic study of 83 cases. Cancer 67:2311-2326, 1991
5. Cerroni L, Arzberger E, Putz B, et al: Primary cutaneous follicle center cell lymphoma with follicular growth pattern. Blood 95:3922-3928, 2000
6. Garcia CF, Weiss LM, Warnke RA: Small noncleaved cell lymphoma: An immunophenotypic study of 18 cases and comparison with large cell lymphoma. Hum Pathol 17:454-461, 1986
7. Willemze R, Meijer CJ, Scheffer E, et al: Diffuse large cell lymphomas of follicular center cell origin presenting in the skin: A clinicopathologic and immunologic study of 16 patients. Am J Pathol 126:325-333, 1987
8. Geelen FA, Vermeer MH, Meijer CJ, et al: Bcl-2 protein expression in primary cutaneous large B-cell lymphoma is site-related. J Clin Oncol 16: 2080-2085, 1998
9. Hoefnagel JJ, Vermeer MH, Jansen PM, et al: Bcl-2, Bcl-6 and CD10 expression in cutaneous B-cell lymphoma: Further support for a follicle centre cell origin and differential diagnostic significance. Br J Dermatol 149:1183-1191, 2003
10. Hoefnagel JJ, Dijkman R, Basso K, et al: Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling. Blood 105:3671-3678, 2004
11. de Leval L, Harris NL, Longtine J, et al: Cutaneous b-cell lymphomas of follicular and marginal zone types: Use of Bcl-6, CD10, Bcl-2, and CD21 in differential diagnosis and classification. Am J Surg Pathol 25:732-741, 2001
12. Vermeer MH, Geelen FA, van Haselen CW, et al: Primary cutaneous large B-cell lymphomas of the legs: A distinct type of cutaneous B-cell lymphoma with an intermediate prognosis - Dutch Cutaneous Lymphoma Working Group. Arch Dermatol 132: 1304-1308, 1996
13. Willemze R, Kerl H, Sterry W, et al: EORTC classification for primary cutaneous lymphomas: A proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 90:354-371, 1997
14. Hallermann C, Kaune KM, Siebert R, et al: Chromosomal aberration patterns differ in subtypes of primary cutaneous B cell lymphomas. J Invest Dermatol 122:1495-1502, 2004
15. Hallermann C, Kaune KM, Gesk S, et al: Molecular cytogenetic analysis of chromosomal breakpoints in the IGH, MYC, BCL6, and MALT1 gene loci in primary cutaneous B-cell lymphomas. J Invest Dermatol 123:213-219, 2004
16. Knijnenburg J, Szuhai K, Giltay J, et al: Insights from genomic microarrays into structural chromosome rearrangements. Am J Med Genet A 132:36-40, 2005
17. Raap AK, van der Burg MJ, Knijnenburg J, et al: Array comparative genomic hybridization with cyanin cis-platinum-labeled DNAs. Biotechniques 37:130-134, 2004
18. Haralambieva E, Kleiverda K, Mason DY, et al: Detection of three common translocation breakpoints in non-Hodgkin's lymphomas by fluorescence in situ hybridization on routine paraffin-embedded tissue sections. J Pathol 198:163-170, 2002
19. Jordanova ES, Riemersma SA, Philippo K, et al: Hemizygous deletions in the HLA region account for loss of heterozygosity in the majority of diffuse large B-cell lymphomas of the testis and the central nervous system. Genes Chromosomes Cancer 35: 38-48, 2002
20. van Doorn R, Zoutman WH, Dijkman R, et al: Epigenetic profiling of cutaneous T-cell lymphoma: Promoter hypermethylation of multiple tumor suppressor genes including BCL7a, PTPRG, and p73. J Clin Oncol 23:3886-3896, 2005
21. Jaffe ES, Sander CA, Flaig MJ: Cutaneous lymphomas: A proposal for a unified approach to classification using the R.E.A.L/WHO Classification. Ann Oncol 11:17-21, 2000 (suppl 1)
22. Goodlad JR, Krajewski AS, Batstone PJ, et al: Primary cutaneous diffuse large B-cell lymphoma: Prognostic significance of clinicopathological subtypes. Am J Surg Pathol 27:1538-1545, 2003
23. Paulli M, Viglio A, Vivenza D, et al: Primary cutaneous large B-cell lymphoma of the leg: Histogenetic analysis of a controversial clinicopathologic entity. Hum Pathol 33:937-943, 2002
24. Yap LM, Blum R, Foley P, et al: Clinical study of primary cutaneous B-cell lymphoma using both the European Organization for Research and Treatment of Cancer and World Health Organization classifications. Australas J Dermatol 44:110-115, 2003
25. Rao PH, Houldsworth J, Dyomina K, et al: Chromosomal and gene amplification in diffuse large B-cell lymphoma. Blood 92:234-240, 1998
26. Martinez-Climent JA, Alizadeh AA, Segraves R, et al: Transformation of follicular lymphoma to diffuse large cell lymphoma is associated with a heterogeneous set of DNA copy number and gene expression alterations. Blood 101:3109-3117, 2003
27. Joos S, Otano-Joos MI, Ziegler S, et al: Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene. Blood 87:1571-1578, 1996
28. Joos S, Menz CK, Wrobel G, et al: Classical Hodgkin lymphoma is characterized by recurrent copy number gains of the short arm of chromosome 2. Blood 99:1381-1387, 2002
29. Barth TF, Dohner H, Werner CA, et al: Characteristic pattern of chromosomal gains and losses in primary large B-cell lymphomas of the gastrointestinal tract. Blood 91:4321-4330, 1998
30. Barth TF, Martin-Subero JI, Joos S, et al: Gains of 2p involving the REL locus correlate with nuclear c-Rel protein accumulation in neoplastic cells of classical Hodgkin lymphoma. Blood 101: 3681-3686, 2003
31. Rosenwald A, Wright G, Chan WC, et al: The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 346:1937-1947, 2002
32. Child FJ, Russell-Jones R, Woolford AJ, et al: Absence of the t(14;18) chromosomal translocation in primary cutaneous B-cell lymphoma. Br J Dermatol 144:735-744, 2001
33. Mao X, Lillington D, Child F, et al: Comparative genomic hybridization analysis of primary cutaneous B-cell lymphomas: Identification of common genomic alterations in disease pathogenesis. Genes Chromosomes Cancer 35:144-155, 2002
34. Monni O, Joensuu H, Franssila K, et al: DNA copy number changes in diffuse large B-cell lymphoma: Comparative genomic hybridization study. Blood 87:5269-5278, 1996
35. Wessendorf S, Schwaenen C, Kohlhammer H, et al: Hidden gene amplifications in aggressive B-cell non-Hodgkin lymphomas detected by microarray-based comparative genomic hybridization. Oncogene 22:1425-1429, 2003
36. Sanchez-Izquierdo D, Buchonnet G, Siebert R, et al: MALT1 is deregulated by both chromosomal translocation and amplification in B-cell non-Hodgkin lymphoma. Blood 101:4539-4546, 2003
37. Tagawa H, Suguro M, Tsuzuki S, et al: Comparison of genome profiles for identification of distinct subgroups of diffuse large B-cell lymphoma. Blood 106:1770-1777, 2005
38. Child FJ, Scarisbrick JJ, Calonje E, et al: Inactivation of tumor suppressor genes p15(INK4b) and p16(INK4a) in primary cutaneous B cell lymphoma. J Invest Dermatol 118:941-948, 2002
39. Okuda T, Shurtleff SA, Valentine MB, et al: Frequent deletion of p16INK4a/MTS1 and p15INK4b/ MTS2 in pediatric acute lymphoblastic leukemia. Blood 85:2321-2330, 1995
40. Olopade OI, Bohlander SK, Pomykala H, et al: Mapping of the shortest region of overlap of deletions of the short arm of chromosome 9 associated with human neoplasia. Genomics 14: 437-443, 1992
41. Pollak C, Hagemeijer A: Abnormalities of the short arm of chromosome 9 with partial loss of material in hematological disorders. Leukemia 1:541-548, 1987
42. Heyman M, Rasool O, Borgonovo BL, et al: Prognostic importance of p15INK4B and p16INK4 gene inactivation in childhood acute lymphocytic leukemia. J Clin Oncol 14:1512-1520, 1996
43. Kees UR, Burton PR, Lu C, et al: Homozygous deletion of the p16/MTS1 gene in pediatric acute lymphoblastic leukemia is associated with unfavorable clinical outcome. Blood 89:4161-4166, 1997
44. Zhou M, Gu L, Yeager AM, et al: Incidence and clinical significance of CDKN2/MTS1/P16ink4A and MTS2/P15ink4B gene deletions in childhood acute lymphoblastic leukemia. Pediatr Hematol Oncol 14:141-150, 1997
45. Raschke S, Balz V, Efferth T, et al: Homozygous deletions of CDKN2A caused by alternative mechanisms in various human cancer cell lines. Genes Chromosomes Cancer 42:58-67, 2005